Machine learning in drug discovery: a review

S Dara, S Dhamercherla, SS Jadav, CHM Babu… - Artificial intelligence …, 2022 - Springer
This review provides the feasible literature on drug discovery through ML tools and
techniques that are enforced in every phase of drug development to accelerate the research …

Artificial intelligence and machine learning technology driven modern drug discovery and development

C Sarkar, B Das, VS Rawat, JB Wahlang… - International Journal of …, 2023 - mdpi.com
The discovery and advances of medicines may be considered as the ultimate relevant
translational science effort that adds to human invulnerability and happiness. But advancing …

A unified drug–target interaction prediction framework based on knowledge graph and recommendation system

Q Ye, CY Hsieh, Z Yang, Y Kang, J Chen, D Cao… - Nature …, 2021 - nature.com
Prediction of drug-target interactions (DTI) plays a vital role in drug development in various
areas, such as virtual screening, drug repurposing and identification of potential drug side …

A review on applications of computational methods in drug screening and design

X Lin, X Li, X Lin - Molecules, 2020 - mdpi.com
Drug development is one of the most significant processes in the pharmaceutical industry.
Various computational methods have dramatically reduced the time and cost of drug …

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions

TN Jarada, JG Rokne, R Alhajj - Journal of cheminformatics, 2020 - Springer
Drug repositioning is the process of identifying novel therapeutic potentials for existing drugs
and discovering therapies for untreated diseases. Drug repositioning, therefore, plays an …

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

S Vatansever, A Schlessinger, D Wacker… - Medicinal research …, 2021 - Wiley Online Library
Neurological disorders significantly outnumber diseases in other therapeutic areas.
However, developing drugs for central nervous system (CNS) disorders remains the most …

Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions

A Dhakal, C McKay, JJ Tanner… - Briefings in …, 2022 - academic.oup.com
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …

DeepDTA: deep drug–target binding affinity prediction

H Öztürk, A Özgür, E Ozkirimli - Bioinformatics, 2018 - academic.oup.com
Motivation The identification of novel drug–target (DT) interactions is a substantial part of the
drug discovery process. Most of the computational methods that have been proposed to …

iGRLDTI: an improved graph representation learning method for predicting drug–target interactions over heterogeneous biological information network

BW Zhao, XR Su, PW Hu, YA Huang, ZH You… - …, 2023 - academic.oup.com
Motivation The task of predicting drug–target interactions (DTIs) plays a significant role in
facilitating the development of novel drug discovery. Compared with laboratory-based …

Compound–protein interaction prediction with end-to-end learning of neural networks for graphs and sequences

M Tsubaki, K Tomii, J Sese - Bioinformatics, 2019 - academic.oup.com
Motivation In bioinformatics, machine learning-based methods that predict the compound–
protein interactions (CPIs) play an important role in the virtual screening for drug discovery …